ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

Virology Contract Phaseout To Cut $5 Million In FY 1980; Bigger reduction Coming In 1982

July 27, 1979

Hairy Cell Leukemia Patients Have CRs In Phase I Trial

September 28, 2001

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

In Brief: Reginald Ho Assumes ACS Presidency; Board Calls On NCI To Fully Fund ASSIST Program

November 13, 1992

In Brief: Money Buys Progress In Cancer Research, DeVita says; John Montgomery To Give Clowes Lecture

April 29, 1983

Study: Partial Kidney Removal Leads to Greater Survival

March 29, 2013